13‑<em>cis</em>‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells

Butsri,Siriwoot; Kukongviriyapan,Veerapol; Senggunprai,Laddawan; Kongpetch,Sarinya; Prawan,Auemduan

doi:10.3892/ijmm.2023.5223

13‑cis‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells

Authors:
- Siriwoot Butsri
- Veerapol Kukongviriyapan
- Laddawan Senggunprai
- Sarinya Kongpetch
- Auemduan Prawan
View Affiliations

Affiliations: Department of Pharmacology, Faculty of Medicine, Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand, Department of Pharmacology, Faculty of Medicine, Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand
Published online on: January 20, 2023 https://doi.org/10.3892/ijmm.2023.5223
Article Number: 20
Copyright: © Butsri et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

13‑cis‑retinoic acid (13CRA), a Food and Drug Administration‑approved drug for severe acne, is currently being investigated for its potential use in skin cancer prevention. 13CRA has been reported to exhibit antitumor effects against various types of cancer cells, both in vitro and in vivo. However, to the best of our knowledge, no information is yet available regarding the effects of 13CRA on cholangiocarcinoma (CCA), a malignancy of the bile duct epithelia. Currently, there are no reliably effective therapeutic options for metastatic CCA. The present study thus aimed to evaluate the effects of 13CRA on the self‑renewal, migration, invasion and adhesion of CCA cells, and also investigated the underlying mechanisms. The results revealed that 13CRA suppressed cell proliferation via the inhibition of the self‑renewal ability of CCA cells. 13CRA induced cell cycle arrest at the G₂/M phase in KKU‑100 and KKU‑213B CCA cells through the regulation of cell cycle‑regulatory genes and proteins. 13CRA reduced the cell migratory ability of both cell lines via the modulation of the genes and proteins associated with epithelial‑mesenchymal transition. 13CRA also inhibited the invasive and adhesive abilities of CCA cells via the suppression of genes and proteins associated with the invasion and adhesion of CCA cells. On the whole, these results suggested that 13CRA exerts suppressive effects on CCA cell proliferation, migration, adhesion and invasion.

View Figures

View References

1	Meyskens FL Jr, Goodman GE and Alberts DS: 13-Cis-retinoic acid: Pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. Crit Rev Oncol Hematol. 3:75–101. 1985. View Article : Google Scholar
2	Blaner WS: Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol. 45:S129–S135. 2001. View Article : Google Scholar
3	Layton A: The use of isotretinoin in acne. Dermatoendocrinol. 1:162–169. 2009. View Article : Google Scholar
4	Avis I, Mathias A, Unsworth EJ, Miller MJ, Cuttitta F, Mulshine JL and Jakowlew SB: Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: Importance of bioavailability. Cell Growth Differ. 6:485–492. 1995.PubMed/NCBI
5	Jiang SY, Shyu RY, Chen HY, Lee MM, Wu KL and Yeh MY: In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid. Oncology. 53:334–340. 1996. View Article : Google Scholar : PubMed/NCBI
6	Toma S, Isnardi L, Raffo P, Dastoli G, De Francisci E, Riccardi L, Palumbo R and Bollag W: Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction. Int J Cancer. 70:619–627. 1997. View Article : Google Scholar
7	Adachi Y, Itoh F, Yamamoto H, Iku S, Matsuno K, Arimura Y and Imai K: Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer. Tumour Biol. 22:247–253. 2001. View Article : Google Scholar
8	Guruvayoorappan C, Pradeep CR and Kuttan G: 13-cis-retinoic acid induces apoptosis by modulating caspase-3, bcl-2, and p53 gene expression and regulates the activation of transcription factors in B16F-10 melanoma cells. J Environ Pathol Toxicol Oncol. 27:197–207. 2008. View Article : Google Scholar
9	Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 17:557–588. 2020. View Article : Google Scholar :
10	Blechacz B: Cholangiocarcinoma: Current knowledge and new developments. Gut Liver. 11:13–26. 2017. View Article : Google Scholar :
11	Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B and Hong ST: Epidemiology of cholangio-carcinoma: An update focusing on risk factors. Cancer Sci. 101:579–585. 2010. View Article : Google Scholar
12	Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, Bridgewater J and Okusaka T: Cisplatin and gemcitabine for advanced biliary tract cancer: A meta-analysis of two randomised trials. Ann Oncol. 25:391–398. 2014. View Article : Google Scholar
13	Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 35(Suppl): S25–S54. 2015. View Article : Google Scholar
14	Miller DM, Thomas SD, Islam A, Muench D and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res. 18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI
15	Nelson AM, Gilliland KL, Cong Z and Thiboutot DM: 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 126:2178–2189. 2006. View Article : Google Scholar : PubMed/NCBI
16	Guan X: Cancer metastases: Challenges and opportunities. Acta Pharm Sin B. 5:402–418. 2015. View Article : Google Scholar : PubMed/NCBI
17	Tiwari N, Gheldof A, Tatari M and Christofori G: EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
18	Vaquero J, Guedj N, Clapéron A, Nguyen Ho-Bouldoires TH, Paradis V and Fouassier L: Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. J Hepatol. 66:424–441. 2017. View Article : Google Scholar
19	Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, et al: Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology. 58:1042–1053. 2013. View Article : Google Scholar : PubMed/NCBI
20	Techasen A, Loilome W, Namwat N, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Tumour Biol. 35:8645–8652. 2014. View Article : Google Scholar : PubMed/NCBI
21	Fares J, Fares MY, Khachfe HH, Salhab HA and Fares Y: Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct Target Ther. 5:282020. View Article : Google Scholar : PubMed/NCBI
22	Dustin ML, Rothlein R, Bhan AK, Dinarello CA and Springer TA: Induction by IL 1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986.137:245–254. View Article : Google Scholar J Immunol. 186:5024–5033. 2011.
23	Fosslien E: Review: Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci. 31:325–348. 2001.PubMed/NCBI
24	Wagenaar-Miller RA, Hanley G, Shattuck-Brandt R, DuBois RN, Bell RL, Matrisian LM and Morgan DW: Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. Br J Cancer. 88:1445–1452. 2003. View Article : Google Scholar : PubMed/NCBI
25	Itatsu K, Sasaki M, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Zen Y, Sato H, et al: Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. Am J Pathol. 174:829–841. 2009. View Article : Google Scholar : PubMed/NCBI
26	Tuponchai P, Kukongviriyapan V, Prawan A, Kongpetch S and Senggunprai L: Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway. J Cancer Res Ther. 15:157–163. 2019.
27	Kaewmeesri P, Kukongviriyapan V, Prawan A, Kongpetch S and Senggunprai L: Cucurbitacin B diminishes metastatic behavior of cholangiocarcinoma cells by suppressing focal adhesion kinase. Asian Pac J Cancer Prev. 22:219–225. 2021. View Article : Google Scholar : PubMed/NCBI
28	Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C and Miwa M: Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol. 11:3392–3397. 2005. View Article : Google Scholar : PubMed/NCBI
29	Sripa B, Seubwai W, Vaeteewoottacharn K, Sawanyawisuth K, Silsirivanit A, Kaewkong W, Muisuk K, Dana P, Phoomak C, Lert-Itthiporn W, et al: Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Hum Cell. 33:695–708. 2020. View Article : Google Scholar : PubMed/NCBI
30	Butsri S, Kukongviriyapan V, Senggunprai L, Kongpetch S and Prawan A: All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. Oncol Lett. 23:1792022. View Article : Google Scholar : PubMed/NCBI
31	Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013. View Article : Google Scholar :
32	Guruvayoorappan C and Kuttan G: 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation. J Exp Ther Oncol. 7:173–182. 2008.PubMed/NCBI
33	Chung KD, Jeong YI, Chung CW, Kim DH and Kang DH: Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells. Int J Pharm. 422:454–461. 2012. View Article : Google Scholar
34	Veal GJ, Cole M, Errington J, Pearson AD, Foot AB, Whyman G and Boddy AV; UKCCSG Pharmacology Working Group: Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma-a study of the United Kingdom children's cancer study group. Br J Cancer. 96:424–431. 2007. View Article : Google Scholar : PubMed/NCBI
35	Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E, Boeuf H, Gauthereau X, Rousseau B, Fevre M, et al: All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth. Oncogene. 35:5619–5628. 2016. View Article : Google Scholar : PubMed/NCBI
36	Ozeki M and Shively JE: Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells. J Leukoc Biol. 84:769–779. 2008. View Article : Google Scholar : PubMed/NCBI
37	Zhang H, Satyamoorthy K, Herlyn M and Rosdahl I: All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells-a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis. 24:185–191. 2003. View Article : Google Scholar
38	Zhang H and Rosdahl I: Expression of p27 and MAPK proteins involved in all-trans retinoic acid-induced apoptosis and cell cycle arrest in matched primary and metastatic melanoma cells. Int J Oncol. 25:1241–1248. 2004.
39	Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F: Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood. 99:2199–2206. 2002. View Article : Google Scholar : PubMed/NCBI
40	Cui J, Gong M, He Y, Li Q, He T and Bi Y: All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro. Int J Oncol. 48:349–357. 2016. View Article : Google Scholar
41	Shi G, Zheng X, Wu X, Wang S, Wang Y and Xing F: All-trans retinoic acid reverses epithelial-mesenchymal transition in paclitaxel-resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions. Cancer Sci. 110:379–388. 2019. View Article : Google Scholar
42	Speyer MT, Jackson JA and Burkey BB: The effects of 13-cis retinoic acid on squamous cell carcinoma proliferation and adhesion to extracellular matrix proteins. Laryngoscope. 107:44–48. 1997. View Article : Google Scholar : PubMed/NCBI
43	Jiang C, Wang Q, Xu Z, Li WS, Chen C, Yao XQ and Liu FK: Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer. Am J Cancer Res. 5:2012–2021. 2015.PubMed/NCBI
44	Saensa-Ard S, Leuangwattanawanit S, Senggunprai L, Namwat N, Kongpetch S, Chamgramol Y, Loilome W, Khansaard W, Jusakul A, Prawan A, et al: Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. Tumour Biol. 39:10104283177259252017. View Article : Google Scholar : PubMed/NCBI
45	Madzharova E, Kastl P, Sabino F and Auf dem Keller U: Post-translational modification-dependent activity of matrix metalloproteinases. Int J Mol Sci. 20:30772019. View Article : Google Scholar : PubMed/NCBI